Is oral sotalol effective in converting atrial fibrillation to sinus rhythm?

Pharmacotherapy

Volumn 17, Issue 6, 1997, Pages 1233-1237

  Ferreira, Ema ^a   Sunderji, Rubina ^a,b   Gin, Kenneth ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROPAFENONE; QUINIDINE; SOTALOL;

BRADYCARDIA; CLINICAL TRIAL; DRUG INDUCED DISEASE; DRUG RESEARCH; DRUG SCREENING; HEART ATRIUM FIBRILLATION; HUMAN; MEDICAL INFORMATION; NAUSEA; REVIEW; SINUS RHYTHM; VOMITING;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; HUMANS; SINOATRIAL NODE; SOTALOL;

EID: 0030707667     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Cuddy TE, Connolly SJ. Atrial fibrillation and atrial flutter. Can J Cardiol 1996;12(suppl A):9A-11.
2. Geraets DR, Kienzle MG. Atrial fibrillation and atrial flutter. Clin Pharm 1993;12:721-35.
3. Nattel S, Hadjis T, Talajic M. The treatment of atrial fibrillation: an evaluation of drug therapy, electrical modalities and therapeutic considerations. Drugs 1994;48:345-71.
4. Symanski JD, Gettes LS. Drug effects on the electro-cardiogram. Drugs 1993;46:219-48.
5. Suttorp MJ, Kingma JH, Peels HOJ, et al. Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting. Am J Cardiol 1991;68:1163-9.
6. Janssen J, Loomans L, Harink J, et al. Prevention and treatment of supraventricular tachycardia shortly after coronary artery bypass grafting: a randomized open trial. Angiology 1986;37:601-9.
7. Antman EM, Beamer AD, Cantillon C, McGowan N, Friedman PL. Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs. J Am Coll Cardiol 1990;15:698-707.
8. Singh S, Saini RK, DiMarco J, et al. Efficacy and safety of sotalol in digitalized patients with chronic atrial fibrillation. Am J Cardiol 1991;68:1227-30.
9. Halinen MO, Huttunen M, Paakkinen S, Tarssanen L. Comparison of sotalol with digoxin-quinidine for conversion of acute atrial fibrillation to sinus rhythm (the sotalol-digoxin-quinidine trial). Am J Cardiol 1995;76:495-8.
10. Hohnloser SH, Van de Loo A, Baedeker F. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine. J Am Coll Cardiol 1995;26:852-8.
11. Talajic M, MacDonald R, Nattel S. Restoration of sinus rhythm in patients with atrial fibrillation. Can J Cardiol 1996;12(suppl A):29A-35.
12. Perks W, Stumpo C, Jurewitsch B, Klem C. Therapeutic alternatives in atrial fibrillation. Can J Hosp Pharm 1995; 48:360-4.
13. Hohnloser S, Woosley R. Sotalol. N Engl J Med 1994; 331:31-8.
14. Newman D, Gillis A, Gilbert M, Dorian P. Chronic drug therapy to prevent recurrence of atrial fibrillation. Can J Cardiol 1996;12(suppl A):24A-8.